Inventor · disambiguated record
Ulrich Sensfuss
Also filed as: SENSFUSS ULRICH
9 granted patents·25 pending applications·47 citations·filing 2003–2024
84Inventor score
Top patents by PatentIndex Score
34 records- 0191US7541430B2Peptides for use in treating obesityNOVO NORDISK AS·Filed 2005·Granted Jun 2, 2009·28 cites·72 claims
- 0284US8541368B2Glucagon analoguesNOVO NORDISK AS·Filed 2012·Granted Sep 24, 2013·6 cites·41 claims
- 0383US7517854B2Melanocortin receptor agonistsNOVO NORDISK AS·Filed 2006·Granted Apr 14, 2009·9 cites·31 claims
- 0476US9486505B2Glucagon analoguesNOVO NORDISK AS·Filed 2013·Granted Nov 8, 2016·2 cites·23 claims
- 0571US9486506B2Glucagon analoguesNOVO NORDISK AS·Filed 2015·Granted Nov 8, 2016·1 cites·17 claims
- 0670US2021024604A1Novel insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 0768US9988430B2Stable GLP-1 based GLP-1/glucagon receptor co-agonistsNOVO NORDISK AS·Filed 2015·Granted Jun 5, 2018·1 cites·29 claims
- 0868US2020172593A1Insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 0963US2016229902A1Novel Insulin DerivativesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1061US2018371045A1Novel insulin derivativesNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 1157US2010173835A1Peptides for Treatment of ObesityNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 1255US2012021973A1Peptides for Treatment of ObesityLAU JESPER F·Filed 2009·Application pending·0 cites
- 1354US9751927B2Stable, protracted GLP-1/glucagon receptor co-agonists for medical useNOVO NORDISK AS·Filed 2016·Granted Sep 5, 2017·0 cites·3 claims
- 1454US2016347812A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1554US2024350647A1Sting sensitizing agentsSTIPE THERAPEUTICS APS·Filed 2024·Application pending·0 cites
- 1653US2018044394A1Stable, protracted glp-1/glucagon receptor co-agonists for medical useNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1750US2012184487A1Insulin derivativesHOEG-JENSEN THOMAS·Filed 2010·Application pending·0 cites
- 1849US9474790B2Stable, protracted GLP-1/glucagon receptor co-agonists for medical useNOVO NORDISK AS·Filed 2015·Granted Oct 25, 2016·0 cites·26 claims
- 1947US2010016238A1Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2047US2009088388A1Peptides for Use In Treating ObesityNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2146US2010056433A1Novel Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2244US2022184184A1Glucose sensitive insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 2344US2010016237A1Novel Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2442US2014031278A1Novel Glucagon AnaloguesLAU JESPER F·Filed 2012·Application pending·0 cites
- 2542US2007185128A1Compounds and compositions for treating obesityCONDE-FRIEBOES KILIAN W·Filed 2003·Application pending·0 cites
- 2641US2008280820A1Novel Peptides for Use in the Treatment of ObesitySENSFUSS ULRICH·Filed 2005·Application pending·0 cites
- 2740US2008306008A1Peptides for Use in the Treatment of ObesityNOVA NORDISK AS·Filed 2005·Application pending·0 cites
- 2840US2009203581A1Novel Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2938US2015368313A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 3038US2011098213A1Novel peptides for use in the treatment of obesityNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3137US2017008928A1Novel peptides and peptide derivatives and uses thereofNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 3236US2008039387A1Novel Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3335US10570184B2GLP-1/glucagon receptor co-agonists for medical useNOVO NORDISK AS·Filed 2015·Granted Feb 25, 2020·0 cites·19 claims
- 3435US2013012432A1Peptides for Treatment of ObesityNOVO NORDISK AS·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →